how does glp 1 lower blood pressure GLP-1 drugs tied to risks in certain patients, study finds. MORE⬇️ The Effects of GLP-1 on

The guidelines state, GLP-1 RAs may be considered for weight-loss in patients who have completed cancer therapy and may be considered with caution for patients on stable endocrine-based cancer therapies based on limited observational safety data. They also say, GLP-1 RAs cannot be recommended currently for patients receiving or initiating chemotherapies and/or immunotherapies due to lack of safety and outcomes data. Iyengar is director of Survivorship Services at Winship Cancer Institute of Emory University, a clinical member of Winships Glenn Family Breast Center, an associate professor and co-director of the Breast Medical Oncology Program in the Department of Hematology and Medical Oncology at Emory University School of Medicine, and co-editor-in-chief of the journal ONCOLOGY

Blood, 112(6), pp.2214-2221

However, in a secondary analysis, users of GLP-1 RA exhibited a significantly lower risk of hip fracture and a lower risk of MOF compared to DPP-4i users when allowing follow-up to continue after medication change

Handling and Storage Recommendations Proper handling and storage are important to preserve the quality of both peptide components: Keep sealed vials at 20 C, dry, and protected from light